Phase
Condition
Thalassemia
Treatment
No Intervention
Clinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participant must be treated with beti-cel in the post marketing setting at a centerin the US that participates in the Registry.
Participant must sign an informed consent and/or assent prior to enrollment asrequired under applicable laws and regulations.
Participant must have signed an informed consent and/or assent permitting data to beshared with Center for International Blood and Marrow Transplant Research (CIBMTR).
Participant must be followed by a hematologist based in the US.
Exclusion
Exclusion Criteria:
- There are no exclusion criteria for Registry participation.
Study Design
Connect with a study center
UCSF Benioff Children's Hospitals
Oakland, California 94609
United StatesActive - Recruiting
Stanford University
Palo Alto, California 94043
United StatesActive - Recruiting
University of Minnesota
Minneapolis, Minnesota 55455
United StatesActive - Recruiting
Cohen Children's Medical Center
New Hyde Park, New York 11040
United StatesActive - Recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania 19104
United StatesActive - Recruiting
Texas Children's Hospital
Houston, Texas 77030
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.